Annual report pursuant to Section 13 and 15(d)

Accounting for Share-Based Payments

v3.23.1
Accounting for Share-Based Payments
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Accounting for Share-Based Payments Accounting for Share-Based Payments
Overview of Share-Based Payment Plans
The Company has a number of active and inactive equity incentive plans (the "Incentive Plans") under which the Company has been authorized to grant share-based awards to key employees and non-employee directors. On April 25, 2022, the Board of Directors approved, upon the recommendation of the Compensation & Long-Term Incentive Committee but subject to stockholder approval, adoption of the Ascent Industries Co. 2022 Omnibus Equity Incentive Plan (the "Plan") and directed that the Plan be submitted for approval by our stockholders at our 2022 Annual Meeting of Stockholders (the "Annual Meeting"). On June 8, 2022, at the 2022 Annual Meeting, upon the recommendation of the Company's Board of Directors, a majority of the shareholders of the Company voted to approve the Plan. A total of 0.8 million shares have been authorized for grant to key employees and non-employee directors under the Company's currently active Incentive Plans. As of December 31, 2022, there were 0.7 million shares remaining available for grants under the currently active equity Incentive Plans.

The Company recognized share-based compensation expense within SG&A expense on the consolidated statements of income of $1.4 million and $0.8 million in 2022 and 2021, respectively.

Total unrecognized share-based payment expense for all share-based payment plans was $1.5 million at December 31, 2022, of which $1.0 million will be recognized in 2023, $0.4 million in 2024, and $0.1 million thereafter. This results in these amounts being recognized over a weighted-average period of 2.04 years.

Stock Options
Stock options have terms of 10 years and vest in 20% or 33% increments annually on a cumulative basis, beginning one year after the date of grant, and are assigned an exercise price equal to the average of the high and low common stock price on the day prior to the date of grant. Options are expensed on a straight-line basis over the grant vesting period, which is considered to be the requisite service period. Compensation expense charged against income for options was insignificant for 2022 and 2021
The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model. When determining expected volatility, the Company considers the historical volatility of the Company’s stock price. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant, based on the options’ expected term. The Company granted no new options in 2022.
Transactions related to stock options for the year ended December 31, 2022 are summarized as follows:
Weighted
Average
Exercise
Price
Options
Outstanding
Weighted
Average
Contractual
Term
(in years)
Intrinsic
Value of
Options
Outstanding at December 31, 2021 $ 13.04  143,828  6.0 $ 487,011 
Exercised 9.67  (18,098)
Canceled, forfeited, or expired 11.71  (7,588)
Outstanding at December 31, 2022 $ 13.66  118,142  5.2 $ — 
Vested and expected to vest at December 31, 20221
$ 13.00  5,665  7.1 $ — 
Exercisable options $ 13.69  112,477  5.1 $ — 
1Includes outstanding vested and nonvested options
Restricted Stock Awards
Restricted stock awards are valued based on the average of the high and low common stock price on the day prior to the date of grant. In general, these awards vest in either 20% or 33% increments annually on a cumulative basis, beginning one year after the date of grant. Certain of these awards vest 100% at the end of a three-year period from the date of grant. In order for the awards to vest, the employee must be in the continuous employment of the Company since the date of the award. Except for death, disability, or qualifying retirement, any portion of an award that has not vested is forfeited upon termination of employment. An employee is not entitled to any voting rights with respect to any shares not yet vested, and the shares are not transferable.
All awards are expensed on a straight-line basis over the grant vesting period, which is considered to be the requisite service period. The weighted average period over which the restricted stock awards compensation expense is expected to be recognized is 2.31 years.
Transactions related to restricted stock awards for the year ended December 31, 2022 are summarized as follows:
Shares Weighted Average
Grant Date Fair Value
Nonvested at December 31, 2021 43,581  $ 9.82 
Granted 72,110  18.19 
Vested (24,641) 7.75 
Forfeited (11,947) 13.33 
Nonvested at December 31, 2022 79,103  $ 17.31 

Performance Stock Units

The Company issues performance stock units classified as equity awards which contain market conditions that must be satisfied for an employee to earn the right to benefit from the award. Performance stock units vest upon the achievement of specific thirty-day volume-weighted average price targets of a share of the Company's common stock over a period of three years. In order for the awards to vest, the employee must be in the continuous employment of the Company since the date of the award. Except for death, disability, or qualifying retirement, any portion of an award that has not vested is forfeited upon termination of employment. An employee is not entitled to any voting rights with respect to any shares not yet vested, and the shares are not transferable.

The performance stock units are divided into tranches, each one vesting on the date the thirty-day volume-weighted average price of the Company's common stock `meets or exceeds the price target as set forth in the table below:
Shares Volume Weighted Average Price Target
Tranche I 9,663  $ 22.50 
Tranche II 50,000  25.00 
Tranche III 40,000  27.50 
Tranche IV 30,000  30.00 
Tranche V 30,000  $ 35.00 

The fair value of the performance stock units granted with a market performance condition are determined using a Monte Carlo simulation considering historical performance of the Company's stock as well as the probability of attaining the market performance condition determined on the date of grant. Expense is recognized on a straight-line method over the requisite service period. Performance stock units do not have dividend rights. The weighted average period over which the performance stock units compensation expense is expected to be recognized is 2.20 years.
The weighted-average grant-date fair value per unit of performance stock units granted was $3.92 and $0.69 in 2022 and 2021, respectively. There were no performance stock units vesting in 2022. The total fair value of performance stock units vesting was approximately $1.1 million in 2021.

Transactions related to performance stock units for the year ended December 31, 2022 were as follows:
Units Weighted-Average Grant Date Fair Value
Outstanding at December 31, 2021 —  $ — 
Granted 159,663  3.92 
Outstanding at December 31, 2022 159,663  $ 3.92 

Inducement Awards
The Company has previously granted stock-based awards to incoming executive officers as incentives to enter into an at-will employment agreement with the Company. These inducement awards were approved by the Compensation Committee of the Board of Directors and did not require shareholder approval in accordance with NASDAQ Rule 5635(c)(4). In accordance with the rule, the only persons eligible to receive incentive awards are individuals not previously an employee or director of the Company.
In general, 50% of the inducement awards vest based on the achievement of thirty-day volume weighted average price targets of a Company share of stock and 50% vest on the third anniversary of the grant date. The fair value of the market based portion of inducement awards are determined using a Monte Carlo simulation considering historical performance of the Company's stock as well as the probability of attaining the market condition determined on the date of grant. The fair value of the time based portion of inducement awards are determined based on the average of the high and low common stock price on the day prior to the date of grant. Transactions related to inducement stock awards as of December 31, 2022 were as follows:
Units Weighted-Average Grant Date Fair Value
Outstanding December 31, 2021 30,856  $ 8.11 
Vested (9,170) 2.21 
Outstanding December 31, 2022 21,686  $ 10.61 
The total fair value of inducement awards vesting was approximately $0.2 million in 2022 and 2021, respectively. The weighted average period over which inducement award compensation cost is expected to be recognized is 1.52 years.
Non-Employee Director Compensation Plan
Non-employee directors are paid an annual retainer of $102,000, and each director has the opportunity to elect to receive 100% of the retainer in restricted stock, which vest quarterly over a one year period. The number of restricted shares is determined by the average of the high and low sale price of the Company's stock on the day prior to the Annual Meeting of Shareholders. In 2022, the Company issued an aggregate of 17,173 shares of restricted stock to non-employee directors in lieu of $0.3 million of their annual cash retainer fees. The Company also issued an aggregate of 65,000 additional shares of restricted stock to the Company's Executive Chairman of the Board consisting of 15,000 restricted stock units and 50,000 performance stock units. The restricted stock units will vest 50% on the first and second anniversary of the award while the performance stock units vest upon the achievement of specific thirty-day volume weighted average price targets of the Company's common stock. The weighted average period over which the non-employee director award compensation expense is expected to be recognized is 2.04 years.